Volume | 0.00 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Windtree Therapeutics Inc (PK) | WINTW | OTCMarkets | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.01 | 0.01 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0.00 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 0.01 | USD |
Windtree Therapeutics Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
51.48k | 4.78M | - | 0 | -20.29M | -3.94 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Windtree Therapeutics (PK)
Date | Time | Source | Heading |
---|---|---|---|
12/30/2024 | 05:03 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
11/15/2024 | 15:32 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
11/15/2024 | 15:30 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
11/14/2024 | 18:15 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain.. |
11/14/2024 | 14:40 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
10/28/2024 | 16:13 | Edgar (US Regulatory) | Form 8-K - Current report |
10/28/2024 | 16:12 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
10/04/2024 | 16:27 | Edgar (US Regulatory) | Form 8-K - Current report |
10/01/2024 | 16:28 | Edgar (US Regulatory) | Form 8-K - Current report |
10/01/2024 | 07:55 | Edgar (US Regulatory) | Form 8-K - Current report |
9/30/2024 | 07:22 | Edgar (US Regulatory) | Form 8-K - Current report |
9/13/2024 | 16:26 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
WINTW Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
A clinical-stage biopharmaceutical and device company focused on developing novel therapies for acute cardiovascular and pulmonary diseases. Windtree's lead product candidates are being developed to treat acute heart failure and respiratory distress syndrome in premature infants. |